The increased expression of IL21, TET2, AIM2 and c‐MAF and the positive correlation of AIM2 with IL21 or c‐MAF in SLE patients support the potential contribution of the IL‐21‐TET2‐AIM2‐c‐MAF axis to lupus development. This evidence concerns the gene IL21 and systemic lupus erythematosus.